What Happens to the Immune Microenvironment After PD-1 Inhibitor Therapy?

The fruitful results of tumor immunotherapy establish its indispensable status in the regulation of the tumorous immune context. It seems that the treatment of programmed cell death receptor 1 (PD-1) blockade is one of the most promising approaches for cancer control. The significant efficacy of PD-...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qingyi, Xie, Bin, Liu, Shuang, Shi, Ying, Tao, Yongguang, Xiao, Desheng, Wang, Wenxiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733588/
https://www.ncbi.nlm.nih.gov/pubmed/35003090
http://dx.doi.org/10.3389/fimmu.2021.773168

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8733588/
https://www.ncbi.nlm.nih.gov/pubmed/35003090
http://dx.doi.org/10.3389/fimmu.2021.773168

Ejemplares similares